IGC Pharma, Inc.
IGCNYSECIK 1326205HealthcareFiscal year ends Dec 31
Reports and events: 270 filings
Newest first, by EDGAR acceptance time (Eastern). Each filing’s page lists its documents on sec.gov and, for 10-K and 10-Q reports, the extracted sections.
What the forms are: 10-K, 10-Q, 8-K, Form 4, DEF 14A, Schedule 13D, Schedule 13G, amendments, accession numbers.
| Filed | Form | What it is | Accession number |
|---|---|---|---|
| 2026-10-2200:32 ET | DEF 14A | Proxy statementPeriod 2026-12-02 | 0001185185-26-004896 |
| 2026-08-1420:01 ET | 10-Q | Quarterly reportPeriod 2026-06-30 | 0001185185-26-003544 |
| 2026-07-1422:11 ET | 8-K | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001185185-26-002922 |
| 2026-07-0620:02 ET | 8-K | 1.01 Entry into a material agreement; 3.02 Unregistered sale of equity; 9.01 Financial statements and exhibits | 0001185185-26-002808 |
| 2026-06-0820:03 ET | 8-K | 1.01 Entry into a material agreement; 2.03 New direct financial obligation; 9.01 Financial statements and exhibits | 0001185185-26-002410 |
| 2026-05-1520:02 ET | 10-Q | Quarterly reportPeriod 2026-03-31 | 0001185185-26-001885 |
| 2026-04-2020:01 ET | 8-K | 1.01 Entry into a material agreement; 2.03 New direct financial obligation; 3.02 Unregistered sale of equity; 9.01 Financial statements and exhibits | 0001185185-26-001437 |
| 2026-03-3021:43 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0001185185-26-001146 |
| 2026-03-1222:19 ET | 8-K | 1.01 Entry into a material agreement; 2.03 New direct financial obligation; 3.02 Unregistered sale of equity; 9.01 Financial statements and exhibits | 0001185185-26-000846 |
| 2026-01-0623:11 ET | 8-K | 1.01 Entry into a material agreement; 9.01 Financial statements and exhibits | 0001185185-26-000032 |
| 2026-01-0221:02 ET | 8-K | 5.03 Amendment to articles or bylaws | 0001185185-26-000010 |
| 2025-12-1521:02 ET | 8-K | 5.03 Amendment to articles or bylaws; 9.01 Financial statements and exhibits | 0001185185-25-002055 |
| 2025-11-1421:11 ET | 10-Q | Quarterly reportPeriod 2025-09-30 | 0001185185-25-001752 |
| 2025-11-1415:03 ET | 8-K | 2.01 Completion of an acquisition or disposition; 9.01 Financial statements and exhibits | 0001185185-25-001713 |
| 2025-10-1423:49 ET | 8-K | 5.07 Shareholder vote results; 8.01 Other events; 9.01 Financial statements and exhibits | 0001185185-25-001428 |
| 2025-10-0120:40 ET | 8-K | 1.01 Entry into a material agreement; 9.01 Financial statements and exhibits | 0001185185-25-001326 |
| 2025-08-1819:02 ET | DEF 14A | Proxy statementPeriod 2025-10-10 | 0001185185-25-001021 |
| 2025-08-1420:04 ET | 10-Q | Quarterly reportPeriod 2025-06-30 | 0001185185-25-000997 |
| 2025-06-2720:14 ET | 10-K | Annual reportPeriod 2025-03-31 | 0001185185-25-000706 |
| 2025-06-1712:36 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0001185185-25-000657 |
| 2025-02-1421:00 ET | 10-Q | Quarterly reportPeriod 2024-12-31 | 0001185185-25-000137 |
| 2024-11-1221:04 ET | 10-Q | Quarterly reportPeriod 2024-09-30 | 0001185185-24-001096 |
| 2024-09-2720:05 ET | 8-K | 1.01 Entry into a material agreement; 3.02 Unregistered sale of equity; 9.01 Financial statements and exhibits | 0001185185-24-000923 |
| 2024-08-2722:38 ET | 8-K | 5.07 Shareholder vote results; 8.01 Other events; 9.01 Financial statements and exhibits | 0001185185-24-000851 |
| 2024-08-1420:23 ET | SC 13D/A | Ownership report, active investor, amended | 0001185185-24-000811 |
| 2024-08-0720:03 ET | 10-Q | Quarterly reportPeriod 2024-06-30 | 0001185185-24-000766 |
| 2024-08-0218:38 ET | 8-K | 1.01 Entry into a material agreement; 2.03 New direct financial obligation; 9.01 Financial statements and exhibits | 0001185185-24-000755 |
| 2024-07-0820:07 ET | DEF 14A | Proxy statementPeriod 2024-08-23 | 0001185185-24-000674 |
| 2024-06-2417:32 ET | 10-K | Annual reportPeriod 2024-03-31 | 0001185185-24-000650 |
| 2024-05-2101:20 ET | SC 13D | Ownership report, active investor | 0001185185-24-000580 |
| 2024-04-0515:33 ET | 8-K | 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0001185185-24-000360 |
| 2024-03-2822:42 ET | 8-K | 1.01 Entry into a material agreement; 3.02 Unregistered sale of equity; 8.01 Other events; 9.01 Financial statements and exhibits | 0001185185-24-000324 |
| 2024-03-2223:34 ET | 8-K | 1.01 Entry into a material agreement; 9.01 Financial statements and exhibits | 0001185185-24-000301 |
| 2024-03-1313:00 ET | 8-K | 5.02 Departure or appointment of officers or directors; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001185185-24-000233 |
| 2024-02-1421:03 ET | 10-Q | Quarterly reportPeriod 2023-12-31 | 0001185185-24-000160 |
| 2023-11-0922:15 ET | 10-Q | Quarterly reportPeriod 2023-09-30 | 0001185185-23-001163 |
| 2023-10-2721:21 ET | 8-K | 1.01 Entry into a material agreement; 9.01 Financial statements and exhibits | 0001185185-23-001111 |
| 2023-08-2116:44 ET | 8-K | 5.07 Shareholder vote results; 8.01 Other events; 9.01 Financial statements and exhibits | 0001185185-23-000887 |
| 2023-08-1020:10 ET | 10-Q | Quarterly reportPeriod 2023-06-30 | 0001185185-23-000796 |
| 2023-07-2621:26 ET | DEF 14A | Proxy statementPeriod 2023-08-18 | 0001185185-23-000759 |
| 2023-07-0720:15 ET | 10-K | Annual reportPeriod 2023-03-31 | 0001185185-23-000693 |
| 2023-07-0715:41 ET | 8-K | 1.01 Entry into a material agreement; 2.03 New direct financial obligation; 9.01 Financial statements and exhibits | 0001185185-23-000691 |
| 2023-07-0721:52 ET | 8-K | 1.01 Entry into a material agreement; 3.02 Unregistered sale of equity; 9.01 Financial statements and exhibits | 0001185185-23-000688 |
| 2023-05-0822:19 ET | 8-K | 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0001185185-23-000448 |
| 2023-03-2120:50 ET | 8-K | 5.03 Amendment to articles or bylaws; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001185185-23-000238 |
| 2023-02-1421:02 ET | 10-Q | Quarterly reportPeriod 2022-12-31 | 0001185185-23-000133 |
| 2022-12-2914:19 ET | 8-K | 5.02 Departure or appointment of officers or directors | 0001185185-22-001458 |
| 2022-12-2013:23 ET | 8-K | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001185185-22-001432 |
| 2022-11-0120:07 ET | 10-Q | Quarterly reportPeriod 2022-09-30 | 0001185185-22-001243 |
| 2022-09-0920:55 ET | 8-K | 5.02 Departure or appointment of officers or directors; 5.07 Shareholder vote results; 8.01 Other events; 9.01 Financial statements and exhibits | 0001185185-22-001082 |
Source: SEC EDGAR, the company’s filing index. Last ingested by Listed: Oct 24, 2026, 15:11 ET. Listed shows no prices and gives no investment advice.